Heidelberg, Germany

Thomas Eissenloeffel



 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Heidelberg, DE (2019 - 2020)
  • Mannheim, DE (2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Thomas Eissenloeffel

Introduction

Thomas Eissenloeffel, a notable inventor based in Heidelberg, Germany, has made significant strides in the field of medical technology with a portfolio of four patents. His innovative ideas are aimed at enhancing healthcare applications, particularly in diabetes management.

Latest Patents

Among his latest patents are two groundbreaking inventions. The first is titled "Method for validating a medical application, end user device and medical system." This inventive method provides a robust process to ensure the compatibility of medical applications with end user devices. It involves executing a validation process that encompasses determining the hardware and software environment, running a test mode for the medical application, and generating a validation report based on compatibility findings.

The second patent, "Measurement system for measuring the concentration of an analyte with a subcutaneous analyte sensor," describes a sophisticated medical system that includes a control unit and a subcutaneous sensor. This system is designed to record analyte concentrations and generate medical data entries that can be archived without losing previous data, thus supporting effective diabetes management.

Career Highlights

Currently, Thomas Eissenloeffel is associated with Roche Diabetes Care, Inc., where he leverages his expertise to innovate solutions for diabetes management. His work has not only contributed to the company's advancements but has also made a noteworthy impact on healthcare technology.

Collaborations

Throughout his career, Thomas has worked alongside distinguished colleagues such as Kai-Oliver Schwenker and Ralf Schmitz. Their collaborative efforts have fostered an environment of innovation, resulting in the development of critical medical technologies that enhance patient care.

Conclusion

Thomas Eissenloeffel's inventive mindset and dedication to improving medical devices have resulted in significant advancements in healthcare applications. With a promising array of patents and collaborative endeavors, he continues to impact the field of diabetes care and medical technology profoundly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…